Assessment of a novel, capsid-modified adenovirus with an improved vascular gene transfer profile
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Assessment of a novel, capsid-modified adenovirus with an improved vascular gene transfer profile
Authors
Keywords
Adenovirus, Vascular gene therapy, TIMP-3, Vein graft failure
Journal
Journal of Cardiothoracic Surgery
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-08-10
DOI
10.1186/1749-8090-8-183
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Edifoligide and long-term outcomes after coronary artery bypass grafting: PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) 5-year results
- (2012) Renato D. Lopes et al. AMERICAN HEART JOURNAL
- Biodistribution and inflammatory profiles of novel penton and hexon double-mutant serotype 5 adenoviruses
- (2012) Angela C. Bradshaw et al. JOURNAL OF CONTROLLED RELEASE
- Coagulation Factor X Activates Innate Immunity to Human Species C Adenovirus
- (2012) K. Doronin et al. SCIENCE
- Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID)
- (2011) Mariell Jessup et al. CIRCULATION
- Sustained Reduction of Vein Graft Neointima Formation by Ex Vivo TIMP-3 Gene Therapy
- (2011) S. J. George et al. CIRCULATION
- Adenovirus Serotype 5 Neutralizing Antibodies Target both Hexon and Fiber following Vaccination and Natural Infection
- (2011) R. R. Bradley et al. JOURNAL OF VIROLOGY
- Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors
- (2010) R. Alba et al. BLOOD
- Requirements for Receptor Engagement during Infection by Adenovirus Complexed with Blood Coagulation Factor X
- (2010) Angela C. Bradshaw et al. PLoS Pathogens
- Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer
- (2009) R. Alba et al. BLOOD
- Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer
- (2009) M Hedman et al. GENE THERAPY
- Development and Evaluation of a Novel Gene Delivery Vehicle Composed of Adenovirus Serotype 35
- (2008) Fuminori Sakurai BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Adenovirus Serotype 5 Hexon Mediates Liver Gene Transfer
- (2008) Simon N. Waddington et al. CELL
- Coxsackie- and adenovirus receptor (CAR) is expressed in lymphatic vessels in human skin and affects lymphatic endothelial cell function in vitro
- (2008) Benjamin Vigl et al. EXPERIMENTAL CELL RESEARCH
- Effect of Neutralizing Sera on Factor X-Mediated Adenovirus Serotype 5 Gene Transfer
- (2008) A. L. Parker et al. JOURNAL OF VIROLOGY
- Substitution of Hexon Hypervariable Region 5 of Adenovirus Serotype 5 Abrogates Blood Factor Binding and Limits Gene Transfer to Liver
- (2008) Frédéric Vigant et al. MOLECULAR THERAPY
- Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo
- (2008) O. Kalyuzhniy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started